This case brief covers Supreme Court adopts the misappropriation theory of insider trading and upholds SEC Rule 14e-3 for tender offers.
United States v. O'Hagan is the Supreme Court’s landmark decision endorsing the misappropriation theory of insider trading under Section 10(b) of the Securities Exchange Act of 1934 and SEC Rule 10b-5. Prior to O'Hagan, insider trading liability largely centered on the classical theory—fraud by a corporate insider who trades in the securities of his own corporation based on material nonpublic information, thereby deceiving the company’s shareholders. O'Hagan broadened liability to include a different kind of deception: when a person entrusted with confidential information for a limited purpose exploits that information to trade, thereby defrauding the source of the information.
The Court also upheld Rule 14e-3, a tender-offer-specific rule that prohibits trading on material nonpublic information relating to a tender offer regardless of whether the trader breached a fiduciary duty. Together, these holdings clarified the doctrinal foundations of insider trading, resolved disagreements among lower courts, and strengthened the SEC’s ability to police trading abuses in the sensitive context of mergers and acquisitions.
United States v. O'Hagan, 521 U.S. 642 (1997) (U.S. Supreme Court)
James O’Hagan was a partner at the Minneapolis law firm Dorsey & Whitney. In 1988, the firm represented Grand Metropolitan PLC (Grand Met) in connection with a planned tender offer for the Pillsbury Company. Although O’Hagan was not working on the matter, he learned of the prospective tender offer through his position at the firm. Before the tender offer was publicly announced, O’Hagan secretly purchased a large number of call options and shares of Pillsbury stock. When Grand Met’s tender offer was announced, Pillsbury’s stock price rose, and O’Hagan realized substantial profits—approximately $4.3 million. Federal prosecutors charged O’Hagan with securities fraud under §10(b) and Rule 10b-5 based on the misappropriation theory, tender offer fraud under §14(e) and Rule 14e-3, as well as other offenses. He was convicted in the district court. The Eighth Circuit reversed the securities fraud and Rule 14e-3 convictions, rejecting the misappropriation theory and holding that Rule 14e-3 exceeded the SEC’s authority. The Supreme Court granted certiorari.
Does a person who misappropriates confidential information in breach of a duty owed to the source of the information and uses it for securities trading violate §10(b) and Rule 10b-5? And is SEC Rule 14e-3—which prohibits trading on material nonpublic information in the tender offer context without requiring a breach of fiduciary duty—a valid exercise of the SEC’s authority under §14(e)?
Under the misappropriation theory, a person commits fraud “in connection with” a securities transaction, in violation of §10(b) and Rule 10b-5, when he misappropriates confidential information for securities trading purposes, in breach of a duty of trust and confidence owed to the source of the information. The deception consists of nondisclosure of his intended use of the information to the source to whom he owes the duty, coupled with scienter. The “in connection with” element is satisfied when the deceptive use of confidential information is integral to the securities transaction. Separately, §14(e) authorizes the SEC to adopt prophylactic rules reasonably designed to prevent fraudulent, deceptive, or manipulative acts in connection with tender offers; Rule 14e-3 validly prohibits trading on material nonpublic tender-offer information regardless of whether a fiduciary breach is shown.
Yes. The Supreme Court held that §10(b) and Rule 10b-5 encompass the misappropriation theory: O’Hagan’s undisclosed, self-serving use of confidential information, in breach of a duty owed to the source (his firm and its client), was deceptive and “in connection with” the purchase or sale of securities. The Court also held that Rule 14e-3 is a valid exercise of the SEC’s authority under §14(e) to regulate tender offers by adopting prophylactic measures that do not require proof of a fiduciary breach.
The Court, per Justice Ginsburg, explained that insider trading liability under the classical theory targets corporate insiders who owe duties of trust and confidence to their company’s shareholders and who defraud those shareholders by secretly trading on corporate information. But this is not the only way securities fraud can occur. The misappropriation theory addresses the different wrong of a person who owes a duty of loyalty and confidentiality to the source of information—such as an employer, client, or other confider—and who, without disclosure and consent, uses that information to trade. The deception underlying §10(b) is the fraudulent nondisclosure to the source of the information; by feigning loyalty while secretly converting the information to personal gain, the misappropriator defrauds the source. This approach is consistent with prior jurisprudence, including Chiarella and Dirks, which emphasize a duty-based conception of securities fraud but do not foreclose liability where the duty runs to a different victim. It also coheres with Carpenter, which recognized misappropriation as fraud for mail and wire fraud purposes. On the statutory elements, the Court held that the “in connection with” requirement is satisfied because the deceptive misappropriation was intertwined with the securities trading; the deception made possible, and was executed through, the purchase and sale of securities. The Court emphasized scienter is required for §10(b) liability and found ample evidence that O’Hagan acted with the requisite intent by using confidential tender-offer information for personal trading profits. Turning to the tender-offer counts, the Court upheld Rule 14e-3. Section 14(e) grants the SEC authority to define and prevent fraudulent, deceptive, or manipulative acts in the tender-offer context. The SEC, recognizing the unique pressures and timing sensitivities of tender offers, reasonably adopted a prophylactic rule that prohibits trading while in possession of material nonpublic information relating to a tender offer if the trader knows or has reason to know the information is nonpublic and was acquired from the bidder or target (or their representatives). The Court rejected the Eighth Circuit’s view that §14(e) requires a breach-of-duty element; in the tender-offer arena, Congress authorized the SEC to implement broader protective measures to prevent harm before it occurs. Accordingly, the misappropriation theory falls within §10(b), and Rule 14e-3 is a valid exercise of the SEC’s rulemaking power.
O’Hagan definitively established the misappropriation theory as a basis for insider trading liability, expanding the reach of §10(b) beyond the classical insider–shareholder relationship to cover deception of the source of information. It also confirmed the SEC’s robust authority to craft prophylactic rules for tender offers, validating Rule 14e-3’s possession-based prohibition. For law students, O’Hagan is essential to understanding modern insider trading doctrine: it clarifies the duty structure (duty to source versus duty to shareholders), the role of deception and scienter, the “in connection with” requirement, and the special regulatory treatment of tender offers.
It is the theory that a person commits securities fraud under §10(b) and Rule 10b-5 when he misappropriates confidential information for trading purposes in breach of a duty of trust and confidence owed to the source of the information. The fraud is the undisclosed, self-serving use of the information contrary to the expectations of the person or entity that entrusted it.
Under the classical theory, a corporate insider (or temporary insider) breaches a fiduciary duty to the corporation’s shareholders by trading the corporation’s securities on material nonpublic information. Under misappropriation, the duty is owed to the source of the information (e.g., an employer, client, or deal participant), not to the shareholders of the traded company. Liability attaches when the trader deceives the source by failing to disclose his intended use of the information and trades on it.
The Court held that O’Hagan’s deceptive conduct—his undisclosed use of confidential information entrusted to him—was integrally linked to his securities transactions. The deception enabled and occurred through the trading activity, satisfying the statutory requirement that the fraud be “in connection with” the purchase or sale of securities.
The Court upheld Rule 14e-3 as a valid prophylactic rule promulgated under §14(e). In the tender-offer context, the SEC may prohibit trading on material nonpublic information even absent proof of a fiduciary breach. The rule targets the unique risks and timing concerns of tender offers and is reasonably designed to prevent fraud and manipulation.
As with all §10(b) and Rule 10b-5 violations, scienter is required—at least recklessness, and typically intentional misconduct. In O’Hagan, the evidence showed intentional use of confidential tender-offer information for personal gain without disclosure to the information’s source, satisfying the scienter element.
United States v. O’Hagan reshaped insider trading law by endorsing the misappropriation theory, making clear that the securities laws protect not only shareholders from insider deception but also sources of confidential information from the undisclosed, self-serving misuse of that information. The decision harmonizes the duty-based structure of §10(b) with real-world pathways by which privileged information enters the market.
By also sustaining Rule 14e-3, the Court affirmed the SEC’s authority to craft targeted, prophylactic measures in the tender-offer arena, where informational asymmetries and timing pressures are acute. For students and practitioners, O’Hagan is a foundational case that frames modern insider trading enforcement and compliance, especially in M&A practice and other contexts involving entrusted, market-moving information.